DIAGNOSTICS FOR IVERMECTIN RESISTANCE IN NEMATODES
DIAGNOSTICS FOR IVERMECTIN RESISTANCE IN NEMATODES
批准号:
3489564
负责人:
CARL D JOHNSON
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-03-01 至 1992-08-31
中文摘要
描述:(改编自申请者的摘要)最近,抵抗
驱虫剂已经成为人类面临的最重要的问题
反刍动物寄生线虫的防治。日本血吸虫寄生虫的抗药性
其他具有重要经济意义的动物也被报道过,
毫无疑问,耐药性的发生率将会增加,
最终也会出现在医学上重要的人类寄生虫身上。这个
通过引入伊维菌素,抗药性的影响得到了遏制,
有史以来最有效也是最有效的驱虫剂
发展起来的。然而,最近的报告表明,耐药性的发展
可能很快就会贬值。
模型线虫对伊维菌素耐药性的广泛研究
秀丽隐杆线虫产生了一种关于
寄生线虫中可能存在伊维菌素抗性。的目标
拟议的第一阶段研究将检验假设并确定
寄生线虫中与伊维菌素抗性有关的基因。
在第二阶段,这些基因将被克隆,诊断试剂将能够
将建立检测寄生虫对伊维菌素耐药性的方法。
诊断试剂将为新出现的耐药性和
能够监测旨在限制的新方法的有效性,以及
最好逆转伊维菌素抗性种群的增长(阶段
三)。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) Recently, resistance
to anthelmintics has emerged as the most important problem confronting the
control of parasitic nematodes of ruminants. Resistance in parasites of
other economically significant animals has also been reported and there
can be little doubt that the incidence of resistance will increase and
eventually also appear in medically important parasites of man. The
impact of resistance has been contained by the introduction of ivermectin,
the most potent and arguably the most efficacious anthelmintic ever
developed. However, recent reports suggest that development of resistance
may soon reduce its value.
Extensive investigations of ivermectin resistance in the model nematode
Caenorhabditis elegans have generated a specific hypothesis regarding the
likely form of ivermectin resistance in parasitic nematodes. The goals of
the proposed Phase I research are to test the hypothesis and to identify
the genes responsible for ivermectin resistance in parasitic nematodes.
During Phase II these genes will be cloned and diagnostic reagents capable
of detecting ivermectin resistance in parasites will be developed.
Diagnostic reagents will provide early warning of emerging resistance and
an ability to monitor the efficacy of new methods designed to limit, and
preferably reverse, the growth of ivermectin resistant populations (Phase
III).
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.
人类免疫缺陷病毒 1 型 Tat 蛋白的野生型和反式激活缺陷突变体在体外与人 TATA 结合蛋白结合。
DOI:
10.1097/00042560-199606010-00005
发表时间:
1996
期刊:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
影响因子:
--
作者:
[Wang,Z, Morris,GF, Rice,AP, Xiong,W, Morris,CB]
通讯作者:
Morris,CB
IMPROVING C ELEGANS BASED APOPTOSIS DRUG SCREENS
-
批准号:2331087
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:CARL D JOHNSON
-
依托单位:
NOVEL NEMATODE-BASED SCREEN FOR ANTICANCER AGENTS
-
批准号:2105945
-
项目类别:
-
资助金额:$6.87万
-
财政年份:1994
-
负责人:CARL D JOHNSON
-
依托单位:
IDENTIFYING HUMAN HOMOLOGUES OF C. ELEGANS GENE
-
批准号:3505354
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1992
-
负责人:CARL D JOHNSON
-
依托单位:
NOVEL NEMATODE SPECIFIC ANTHELMINTICS AND NEMATICIDES
-
批准号:3488671
-
项目类别:
-
资助金额:$4.94万
-
财政年份:1988
-
负责人:CARL D JOHNSON
-
依托单位:
NOVEL, NEMATODE-SPECIFIC ANTHELMINTICS AND NEMATICIDES
-
批准号:3506014
-
项目类别:
-
资助金额:$25.02万
-
财政年份:1988
-
负责人:CARL D JOHNSON
-
依托单位:
NOVEL, NEMATODE-SPECIFIC ANTHELMINTICS AND NEMATICIDES
-
批准号:3506013
-
项目类别:
-
资助金额:$24.98万
-
财政年份:1988
-
负责人:CARL D JOHNSON
-
依托单位:
海外基金